Your browser doesn't support javascript.
Development of a road map to scale up the uptake and utilization of influenza vaccine in 22 countries of Eastern Mediterranean Region.
Chughtai, Abrar Ahmad; Mohammed, Shaza; Al Ariqi, Lubna; McCarron, Margaret; Bresee, Joseph; Abubakar, Abdinasir; Khan, Wasiq.
  • Chughtai AA; School of Population Health, University of New South Wales Sydney Australia. Electronic address: abrar.chughtai@unsw.edu.au.
  • Mohammed S; WHO Health Emergencies Programme, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: shmohammed@who.int.
  • Al Ariqi L; WHO Health Emergencies Programme, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt.
  • McCarron M; US Centers for Disease Control, Influenza Division, Atlanta, USA. Electronic address: dme8@cdc.gov.
  • Bresee J; Task Force for Global Health, Atlanta, USA. Electronic address: jbresee@taskforce.org.
  • Abubakar A; WHO Health Emergencies Programme, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: abubakara@who.int.
  • Khan W; WHO Health Emergencies Programme, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: khanwa@who.int.
Vaccine ; 40(45): 6558-6565, 2022 Oct 26.
Article in English | MEDLINE | ID: covidwho-2061960
ABSTRACT

BACKGROUND:

The aim of this project was to develop a road map to support countries in Eastern Mediterranean Region in developing and implementing evidence-based seasonal influenza vaccination policy, strengthen influenza vaccination delivery program and address vaccine misperceptions and hesitancy.

METHODS:

The road map was developed through consultative meetings with countries' focal points, review of relevant literature and policy documents and analysis of WHO/UNICEF Joint Reporting Form on immunization ((JRF 2015-2020) data. Countries were categorised into three groups, based on the existence of influenza vaccination policy and national regulatory authority, availability of influenza vaccine in the country and number of influenza vaccine doses distributed/ 1000 population. The final road map was shared with representatives of all countries in Eastern Mediterranean Region and other stakeholders during a meeting in September 2021.

RESULT:

The goal for next 5 years is to increase access to and use of utilization of seasonal influenza vaccine in Eastern Mediterranean Region to reduce influenza-associated morbidity and mortality among priority groups for vaccination. Countries in the Eastern Mediterranean Region are at different stages of implementation of the influenza vaccination program, so activities are planned under four strategic priority areas based on current situations in countries. The consultative body recommended that some countries should establish a new seasonal influenza vaccination programme and ensure the availability of vaccines, while other countries need to reduce vaccine hesitancy and enhance current seasonal influenza vaccination coverage, particularly in all high-risk groups. Countries are also encouraged to leverage COVID-19 adult vaccination programs to improve seasonal influenza vaccine uptake.

CONCLUSION:

This road map was developed through a consultative process to scale up the uptake and utilization of influenza vaccine in all countries of Eastern Mediterranean Region. The road map proposes activities that should be adopted in the local context to develop/ update national policies and programs.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Humans Country/Region as subject: Europa Language: English Journal: Vaccine Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Humans Country/Region as subject: Europa Language: English Journal: Vaccine Year: 2022 Document Type: Article